FANG YU: Open Payments
NPI 1588097612 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,756 in 73 payments from 16 companies in 2025. Trend: 2023 $1,064 · 2024 $1,331 · 2025 $1,756
Food & beverage: $1,756
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $312 |
| AstraZeneca Pharmaceuticals LP | 8 | $281 |
| GlaxoSmithKline, LLC. | 12 | $204 |
| Amgen Inc. | 10 | $179 |
| BioCryst US Sales Co., LLC | 7 | $157 |
| Novartis Pharmaceuticals Corporation | 8 | $156 |
| Regeneron Healthcare Solutions, Inc. | 3 | $93 |
| CSL Behring | 3 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $62 |
| Lilly USA, LLC | 2 | $53 |
Products named: TEZSPIRE, DUPIXENT, NUCALA, ORLADEYO, XOLAIR, CUVITRU, EBGLYSS, AYVAKIT.
Industry payments across GA — which companies pay providers there.
